person

Efrosyni M.

Country
Greece
Department
2nd Pulmonary Clinic

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
90
Sites with multiple studies

Has run more than one trial at 90 of 129 partner sites.

Specializations

Respiratory Medicine

This investigator specializes in the study and treatment of idiopathic pulmonary fibrosis (IPF), a progressive respiratory condition. Their research focuses on evaluating novel therapeutic approaches for managing this challenging lung disease.

  • IPF Treatment Development
  • Pulmonary Function Assessment
  • Antifibrotic Therapy

The investigator's work explores therapeutic interventions aimed at improving lung function and patient outcomes in IPF.

Clinical Assessment

Their expertise extends to evaluating forced vital capacity (FVC) measurements as a key clinical endpoint in respiratory research. The investigator focuses on establishing efficacy parameters for new therapeutic compounds.

  • Respiratory Function Testing
  • Clinical Endpoints
  • Treatment Response Assessment

Their research encompasses comprehensive evaluation of drug tolerability and safety profiles in respiratory conditions.

Therapeutic Innovation

The investigator's work includes assessment of novel antifibrotic compounds and their potential in treating progressive lung diseases. Their research contributes to advancing treatment options for respiratory disorders.

  • Drug Development
  • Treatment Optimization
  • Clinical Response Evaluation

Their investigations focus on establishing optimal dosing strategies and treatment protocols for respiratory therapeutics.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.